Allurion Technologies publishes Smart Capsule study data in Obesity Surgery

Allurion Technologies (ALUR) announced the publication of the first peer-reviewed study on the consecutive use of the Allurion Smart Capsule, a swallowable, procedure-less weight-loss device. Published in Obesity Surgery, an international journal dedicated to the treatment of obesity and metabolic disease, the multicenter, retrospective study demonstrates that two consecutive treatments can achieve average total body weight loss of 22.1%, results comparable to bariatric surgery and high-dose GLP-1 therapy. The study included 121 overweight adults and adults with obesity across 11 international sites. No serious device-related adverse events were reported.